Literature DB >> 8397367

Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.

X H Liang1, M Volkmann, R Klein, B Herman, S J Lockett.   

Abstract

The loss of the tumor-suppressor activity of p53, either by mutation or by interaction with the human papillomavirus (HPV) E6 protein, is considered to be an important mechanism in the carcinogenesis of cervical cancer. We have studied the cytological distribution of these proteins in human cervical carcinoma cell lines using polyclonal anti-p53 and monoclonal anti-E6 antibodies. The antibody specificity was confirmed by immunoblot and immunocompetition analyses. The intracellular localization of p53 and E6 was detected using the techniques of conventional and three-dimensional confocal microscopy. In the HPV-18 or -16 integrated cell lines, HeLa, CaSki and SiHa, viral oncoprotein E6 and endogenous tumor-suppressor protein, p53, were observed by immunofluorescence in the cytoplasm; p53 also had a weak punctate staining in the nuclei of HeLa and CaSki cells. In the HPV-negative cervical carcinoma cell lines, C-33A and HT-3, which have mutated p53, p53 was localized predominantly to the nucleus, with C-33A cells having elevated levels of p53 compared with the other cell lines. High spatial resolution imaging, using confocal microscopy, was performed on the cells after double fluorescence staining for p53 (fluorescein) and E6 (rhodamine). The images showed that both p53 and E6 had similar cytoplasmic distributions, which implied that these two proteins may exist as a cytoplasmic complex. To substantiate this implication, fluorescence resonance energy transfer microscopy was performed, which provided direct evidence of a close association between p53 and E6 within individual HeLa cells. The results from this study support the theory that p53 protein binds HPV-16/18 E6 protein in the cell cytoplasm, thus preventing p53 from exerting its tumor-suppressor function in the nucleus. Hence, inactivation of wild-type p53 by p53-E6 complex formation in cervical cancer may be a critical step in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397367

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy.

Authors:  G W Gordon; G Berry; X H Liang; B Levine; B Herman
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

3.  Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection.

Authors:  P Nair; K M Nair; P G Jayaprakash; M R Pillai
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Low risk HPV-6E6 induces apoptosis in bone marrow-derived dendritic cells.

Authors:  Lina Sun; Lei Zhao; Dan Li; Shuai Xu; Xuexin Hou; Zhenjun Li
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

Review 5.  Potential of antineoplastons in diseases of old age.

Authors:  S R Burzynski
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

Review 6.  Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  Imaging fluorescence correlation spectroscopy: nonuniform IgE distributions on planar membranes.

Authors:  Z Huang; N L Thompson
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

8.  Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein.

Authors:  X H Liang; L K Kleeman; H H Jiang; G Gordon; J E Goldman; G Berry; B Herman; B Levine
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.

Authors:  D A Freedman; A J Levine
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.

Authors:  Mingfang Tao; Michael Kruhlak; Shuhua Xia; Elliot Androphy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.